Dioxygenase and application thereof in synthesis of vanillin
By introducing dioxygenases Vgdo1 and Vgdo2, replacing CSO2 enzymes, improving the conversion rate and substrate tolerance of vanillin, solving the problems of low efficiency and high cost of biosynthetic vanillin, and achieving vanillin Efficient industrial production.
Patent Information
- Application Number
- CN202411293369.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-11-22
AI Technical Summary
The existing biosynthetic vanillin technology has low conversion efficiency, is difficult to meet the needs of industrial production, and is costly.
Provides dioxygenases Vgdo1 and Vgdo2, which replaces CSO2 enzymes, improves the conversion rate and substrate tolerance of vanillin, through catalytic reactions with ferulic acid, 4-ethyl guaiacol or isoeugenol, Achieve efficient synthesis of vanillin.
It improves the catalytic activity and stability of vanillin, reduces production costs, enhances substrate tolerance, and promotes the industrial production of vanillin.
Smart Images

Figure FT_1 
Figure SMS_1 
Figure SMS_2
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, in particular to a dioxygenase and application thereof in synthesizing vanillin. Background Art
[0002] Vanillin, also known as vanillin, is white or slightly yellow needle-shaped crystals or powder. It is slightly soluble in water and can be slowly oxidized to vanillic acid in humid air. Vanillin has the aroma of vanilla beans and rich milky aroma, and plays a role in flavor enhancement and fixation. It is widely used in cosmetics, tobacco, cakes, candy, baked food and other industries.
[0003] At present, there are three main methods for the production of vanillin: plant raw material extraction, chemical synthesis and biosynthesis. Among them, plant raw material extraction method, this method directly extracts from natural plants such as vanilla beans, but vanilla flowers need to be artificially pollinated during the planting process, which is labor-intensive and difficult to plant on a large scale. This method is costly and has low yields, which cannot meet the growing market demand for natural vanillin; chemical synthesis method, this method uses industrial pulp waste liquid and petrochemicals as raw materials, but chemically synthesized vanillin is inferior to naturally extracted vanillin in purity, aroma, safety, etc., and has a single aroma and is easy to cause environmental pollution, which does not conform to the consumption trend of natural raw materials in the downstream application market, and the waste generated by chemical processes is very harmful to the environment; compared with chemical synthesis, biological synthesis of vanillin has the advantages of mild reaction conditions, few by-products, simple extraction steps, clean production, low environmental pollution, and safe and reliable products.
[0004] With the development of technology, biosynthesis of vanillin has become one of the important ways to obtain this compound. The current biosynthesis methods mainly include the following ways: ferulic acid, eugenol, isoeugenol, vanillyl alcohol, etc. are converted into vanillin under the action of enzymes. With ferulic acid as the substrate, the substrate ferulic acid is catalyzed by Fdc to generate 4-vinylguaiacol, which is further catalyzed by CSO2 dioxygenase to generate vanillin; when isoeugenol is used as the substrate, CSO2 can also be used to promote the conversion of isoeugenol into vanillin without relying on coenzymes.
[0005] At present, it is necessary to improve the production efficiency and reduce the cost of vanillin to meet the growing market demand for natural, high-quality vanillin and realize the industrial production of biosynthetic vanillin. Summary of the invention
[0006] In view of this, the present invention provides a dioxygenase and its application in the synthesis of vanillin. The present invention provides a dioxygenase Vgdo1 or Vgdo2, which can replace the CSO2 enzyme, increase the conversion rate and substrate tolerance, and solve the technical problems of low conversion efficiency and vanillin being unfavorable for industrial production.
[0007] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0008] The present invention provides a dioxygenase, which is dioxygenase 1 or dioxygenase 2;
[0009] The dioxygenase 1 has:
[0010] (1) the amino acid sequence shown in SEQ ID NO: 1; or
[0011] (2) An amino acid sequence obtained by substituting, deleting or adding one or more residues of the amino acid sequence shown in (1), and having the same or similar function as (1); or
[0012] (3) an amino acid sequence having at least 90% homology to the amino acid sequence shown in (1) or (2);
[0013] The dioxygenase 2 has:
[0014] (4) the amino acid sequence shown in SEQ ID NO: 3; or
[0015] (5) An amino acid sequence obtained by substituting, deleting or adding one or more residues of the amino acid sequence shown in (4), and having the same or similar function as (4); or
[0016] (6) An amino acid sequence that is at least 90% homologous to the amino acid sequence shown in (4) or (5).
[0017] The present invention also provides application of the dioxygenase in the preparation of vanillin.
[0018] In some specific embodiments of the present invention, the preparation of the above application can be prepared using at least one of ferulic acid, 4-vinylguaiacol, and isoeugenol as a substrate.
[0019] The present invention also provides a nucleic acid molecule having a nucleotide sequence encoding the above-mentioned dioxygenase;
[0020] The nucleotide sequence is:
[0021] A nucleotide sequence 1 encoding the dioxygenase 1; or
[0022] Nucleotide sequence 2 encoding the dioxygenase 2.
[0023] In some specific embodiments of the present invention, the nucleotide sequence 1 of the above nucleic acid molecule has:
[0024] (7) the nucleotide sequence shown in SEQ ID NO: 2; or
[0025] (8) A nucleotide sequence obtained by replacing, deleting or adding one or more bases of the nucleotide sequence shown in (7), and having the same or similar function as (7); or
[0026] (9) A nucleotide sequence having at least 90% homology to the nucleotide sequence shown in (7) or (8);
[0027] The nucleotide sequence 2 has:
[0028] (10), the nucleotide sequence shown in SEQ ID NO: 4; or
[0029] (11) A nucleotide sequence obtained by replacing, deleting or adding one or more bases of the nucleotide sequence shown in (10), and having the same or similar function as (10); or
[0030] (12) A nucleotide sequence having at least 90% homology to the nucleotide sequence shown in (10) or (11).
[0031] The present invention also provides an expression vector comprising:
[0032] (A1), a nucleotide sequence encoding the above-mentioned dioxygenase; or
[0033] (A2) the above-mentioned nucleic acid molecule.
[0034] In some specific embodiments of the present invention, the backbone of the above expression vector is pSC101, pRSFDuet or pET21a.
[0035] The present invention also provides an expression vector combination, comprising the above expression vector and an expression vector expressing Fdc.
[0036] In some specific embodiments of the present invention, the backbone of the expression vector for expressing Fdc in the above-mentioned expression vector combination is pET28a.
[0037] The present invention also provides a host cell comprising any of the following:
[0038] (B1), the above-mentioned dioxygenase;
[0039] (B2), the above-mentioned nucleic acid molecule;
[0040] (B3), the above-mentioned expression vector;
[0041] (B4) The above expression vector combination.
[0042] In some specific embodiments of the present invention, the host cell may be a bacterium.
[0043] In some specific embodiments of the present invention, the host cell may be Escherichia coli.
[0044] The present invention also provides a method for preparing dioxygenase, which is prepared based on any of the following:
[0045] (C1), the above-mentioned nucleic acid molecule;
[0046] (C2), the above expression vector;
[0047] (C3), the above expression vector combination;
[0048] (C4) or the above host cells.
[0049] In some specific embodiments of the present invention, the preparation method comprises connecting the nucleic acid molecule to an expression vector, transforming a host cell with the expression vector, extracting the protein, and obtaining the dioxygenase.
[0050] In some specific embodiments of the present invention, the above preparation method comprises transforming a host cell with the expression vector, extracting protein, and obtaining the dioxygenase.
[0051] In some specific embodiments of the present invention, the preparation method comprises culturing the host cell, extracting protein, and obtaining the dioxygenase.
[0052] The present invention also provides a method for preparing vanillin, which is prepared based on any of the following:
[0053] (D1), the above-mentioned dioxygenase;
[0054] (D2), the above-mentioned nucleic acid molecule;
[0055] (D3), the above expression vector;
[0056] (D4) the above-mentioned host cells.
[0057] In some specific embodiments of the present invention, the preparation method comprises the steps of reacting the dioxygenase with a substrate;
[0058] The substrate may be at least one of ferulic acid, 4-vinylguaiacol, and isoeugenol.
[0059] In some specific embodiments of the present invention, the above preparation method comprises connecting the nucleic acid molecule to an expression vector, transforming a host cell with the expression vector, and then:
[0060] allowing the strain to contact and react with a substrate to produce vanillin; or
[0061] The protein is extracted to obtain the dioxygenase, and the dioxygenase is contacted with a substrate to obtain vanillin.
[0062] In some specific embodiments of the present invention, the above preparation method comprises transforming a host cell with the expression vector, and then:
[0063] Allowing the host cell to contact and react with the substrate to produce vanillin; or
[0064] The protein is extracted to obtain the dioxygenase, and the dioxygenase is contacted with a substrate to obtain vanillin.
[0065] In some specific embodiments of the present invention, the above preparation method comprises:
[0066] Allowing the host cell to contact and react with the substrate to produce vanillin; or
[0067] The protein is extracted to obtain the dioxygenase, and the dioxygenase is contacted and reacted with a substrate to obtain vanillin.
[0068] In some specific embodiments of the present invention, the preparation method comprises the steps of reacting the dioxygenase with a substrate;
[0069] The substrate concentration of the reaction is 1 g / L, 2 g / L, 3 g / L, 4 g / L, 5 g / L, 6 g / L, 7 g / L, 8 g / L, 9 g / L, 10 g / L, 15 g / L, 20 g / L, 25 g / L, 30 g / L, 35 g / L, 40 g / L, 45 g / L or 50 g / L;
[0070] The temperature of the reaction is 10°C, 15°C, 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 35°C, 36°C, 37°C, 38°C, 39°C or 40°C.
[0071] The dioxygenase of the present invention and its application have the following effects:
[0072] Experiments show that the newly discovered dioxygenase Vgdo1 and dioxygenase Vgdo2 can replace CSO2 enzyme to achieve the synthesis of vanillin, showing good catalytic activity. Compared with CSO2 from traditional sources, the newly discovered dioxygenase Vgdo1 and dioxygenase Vgdo2 have better catalytic activity. In the process of catalyzing the synthesis of vanillin with ferulic acid or isoeugenol as substrate, the conversion rate can be improved, and the cost per unit output is effectively reduced. In addition, the above enzymes have good stability and substrate tolerance. BRIEF DESCRIPTION OF THE DRAWINGS
[0073] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.
[0074] Figure 1 The figure shows the protein electrophoresis results of Vgdo1 and Vgdo2, where Tcp represents total cell protein, S represents soluble protein in the supernatant, and P represents pellet protein in the sediment after centrifugation. DETAILED DESCRIPTION
[0075] The present invention discloses a dioxygenase and its application in the synthesis of vanillin. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It should be particularly noted that all similar substitutions and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.
[0076] The present invention provides a dioxygenase CAO1, named Vgdo1, sourced from Neurospora crassa, and having an amino acid sequence as shown in SEQ ID NO: 1:
[0077] MAEYVFSDAPKDSHGNGVKDAVPGKQPEELPPAPRYFQGENTAGFMRPVRFEGDITNLEVVGEIPKSIEGTFYRVMPEPHLPSFIPNDPWFNGDGNISGFYFKDGHVDLKQRYVRTEKFVREAEARRSLLGKYRNRYTDLVEFKIRSTANTNIVYWRGQLLALKEDSPPYAMDPETLETFGVYDFDGQLPSLTFTAHPKFDPVTREMVCFGYEAKGDGTRDICYYSFGPDGKIAETVWLVSPVCGMIHDFAVTENFVIFPIIPLVCDVERMKQGGDHWQWDYFIPMYIGVLPRRGAQGSDVKWFEAPHGFAGHVANAFEDDKGHIQLQMAYAKDNVFFWWPDANGKGPRPGEVEAHFANFVLDYQSDKLPLAEPTYLVDDDMEFPRIDDRVATRKHKHTFFCIFDRKPGVTDFEFVMPRAGGGAPMSNGLAHLNHETGDIQRYLPGPRKLTGECIFIPRNSEAAEGDGYVMVLLANYEDMCSELAVLDTKDLTNEVALIKLPVRLRPGLHGNWVDKSDVDGHPAPL;
[0078] Its nucleotide sequence can be as shown in SEQ ID NO: 2:
[0079]
[0080] The present invention also provides a dioxygenase LSD4, named Vgdo2, source: Sphingobium, and its amino acid sequence is shown in SEQ ID NO: 3:
[0081] MAHFPDTPAFTGFNAPSRIECDIPNLVHEGTIPPELNGAFFRVQPDPQFPPRLGDDISFNGDGMITRFHIHDGQCDIKQRWAKTNKWKLENAAGKALFGSYRNPLTDDESVKGEYRSTANTN AFVFAGKLWAMKEDSPSLTMDPATMETFGFEKFGGKMTGQTFTAHPKVDPLTGNMVAIGYAASGLCTDDVCLYEISPDGELIYEAWFKVPYYCMMHDFGVTKDYLVLHIVPSIGSWDRLEKGL PHFGFDTTLPVYLGIIPRRADLKQEDIRWFKRENCFAFHVMNAFQEGTKVHVDVPEAENNMFPFFPDVHGAPFNPQQAMSRLTRWTVDMASNSDEFDSVTRLTETAGEFPRIDDRMTGLPYR YGWMLEMDMKRPVELKGGSAGGFLMNCLFLKDHQTGAEQHWWCGPTSSLQEPAFIPRSKDAPEGDGWIVQVCNRLADHKSDLLIFEALDIEKGPVATVHLPFALRFGLHGNWANAEEIGLAA;
[0082] Its nucleotide sequence may be shown as SEQ ID NO: 4:
[0083]
[0084] The amino acid sequence of the carotenoid cleavage oxygenase CSO2 involved in the specific embodiment is shown in SEQ ID NO: 5:
[0085] MDQFVGLHMIYTYENGWEYEIYIKNDHTIDYRIHSGMVGGRWVRDPEVNIVKLTKGVYKVSWTEPTGTDVSLNFMPEEKRMHGVIFFPKWVHERPDITVCYQNDYIDLMKESREKYETYPKYVVPEFADITYIHHAGVNDETIIAEAPYEGLTDEIRAAGRK.
[0086] Unless otherwise specified, the raw materials, reagents, consumables and instruments involved in the present invention are all common commercial products and can be purchased from the market.
[0087] The present invention will be further described below in conjunction with the embodiments.
[0088] Example 1
[0089] 1. Vector Construction
[0090] The sequences of Vgdo1 and Vgdo2 were synthesized respectively, and then introduced into pSC101, pRSFDuet or pET21a vectors by enzyme ligation based on NdeI and XhoI restriction sites to obtain recombinant plasmids.
[0091] The sequence of Fdc was synthesized, and then introduced into the pET28a vector by enzyme ligation based on the NdeI and XhoI restriction sites to obtain pET28a-PT7-Fdc. The ferulic acid decarboxylase Fdc is derived from Bacillus pumilus, and the GenBank accession number is X84815.1.
[0092] And set up a control group:
[0093] As control 1, carotenoid cleavage oxygenase CSO2 (amino acid sequence as shown in SEQ ID NO: 5) from Signeria sibiricus was used. pET21a-PT7-CSO2 was obtained by the same method.
[0094] As control 2, carotenoid oxygenase 1 (hereinafter referred to as NcCAO1) was used, which was derived from Neurospora crassa OR74A, with accession number XP_961764.1. pET21a-PT7-NcCAO1 was obtained by the same method.
[0095] For control 3, carotenoid oxygenase family protein (SCAO) from Sphingobium with accession number WP_014075612.1 was used to obtain pET21a-PT7-SCAO using the same method.
[0096] The recombinant plasmid information is shown in Table 1.
[0097] Table 1: Main information of recombinant plasmid
[0098]
[0099] 2. Construction of recombinant expression bacteria
[0100] Take VANCE001 as an example.
[0101] Streak the BL21(DE3) strain on a non-resistant LB plate, culture overnight at 37°C, pick a single clone and place it in 5 mL LB medium, and culture at 37°C and 200 rpm until the OD 600 About 1.0, collect the bacteria.
[0102] The plasmids pET28a-PT7-Fdc and pSC101-PT7-Vgdo1 were co-transfected into the BL21 (DE3) strain, and plates containing Kan resistance and corresponding resistance were coated and cultured at 37°C overnight. Positive clones were screened by colony PCR, and positive clones were picked and placed in 5 mL of LB medium containing Kan and corresponding resistance, and cultured at 37°C overnight to obtain the vanillin-producing strain VANCE001.
[0103] The construction methods of the remaining strains were the same as above, and the vanillin-producing strains VANCE001~VANCE012 and VANCE-Con01~VANCE-Con03 were obtained respectively. The specific information is shown in Table 2.
[0104] Table 2: Detailed information of recombinant expression bacteria
[0105]
[0106] Example 2
[0107] 1. Single enzyme activity verification
[0108] The recombinant plasmids pET21a-PT7-Vgdo1, pET21a-PT7-Vgdo2, pET21a-PT7-CSO2, pET21a-PT7-NcCAO1, and pET21a-PT7-SCAO constructed in Example 1 were transformed into BL21 (DE3), respectively, to obtain strains BL4V01, BL4V02, BLCon01, BLCon02, and BLCon03.
[0109] Inoculate BL4V01, BL4V02, BLCon01, BLCon02, and BLCon03 into 50 mL of seed culture medium (TB medium) at 37°C and 200 rpm until OD 600 About 0.7, 0.1 mM IPTG was added, and the culture was induced at 20℃ for 18 h. The overnight culture was centrifuged and the supernatant was removed. 0.1 g of the bacteria were ultrasonically broken, and 5 mL of the reaction solution containing 25 g / L isoeugenol (IsEu) and 25 g / L 4-vinylguaiacol (4-VG) was added to react for 4 hours. The reaction temperature was controlled at 30℃. The concentration of vanillin was determined by HPLC, and the results are shown in Table 3. Figure 1 Shown are the protein electrophoresis results of Vgdo1 and Vgdo2.
[0110] Table 3: Single enzyme activity verification
[0111]
[0112] It can be seen from the results that the Vgdo1 and Vgdo2 proposed in the present invention have higher single enzyme activities than CSO2, NcCAO1 and SCAO.
[0113] 2. Verification of single enzyme substrate tolerance
[0114] 2.1 Substrate concentration verification
[0115] In order to verify the conversion ability of Vgdo1 and Vgdo2 to products at different substrate concentrations, different concentrations of isoeugenol or 4-vinylguaiacol were added to the crude enzyme solution as substrates according to the above steps. The specific method is as mentioned above. The results are expressed as the conversion rate of the substrate, as shown in Tables 4 and 5 below:
[0116] Table 4: Single enzyme substrate concentration tolerance verification - using isoeugenol as substrate
[0117]
[0118] Table 5: Single enzyme substrate concentration tolerance verification - using 4-vinylguaiacol as substrate
[0119]
[0120] 2.2 Temperature Verification
[0121] To verify the conversion ability of Vgdo1 and Vgdo2 to products at different temperatures, according to the above steps, four conversion temperatures of 22°C, 30°C, 37°C, and 45°C were set under the condition of 25 g / L substrate. The control experiment was BLCon01, BLCon02, and BLCon03 strains, and the specific methods were referred to above. Among them, the experimental results were based on the conversion rate of the control strain BLCon01 at 30°C as 100%, and the other results were compared with it, and the results are shown in Tables 6 and 7 below.
[0122] Table 6: Temperature tolerance test of single enzyme - using isoeugenol as substrate
[0123]
[0124] Table 7: Temperature tolerance test of single enzyme - using 4-vinylguaiacol as substrate
[0125]
[0126] 3. Biotransformation reaction experimental verification
[0127] The strains VANCE001~VANCE012 and VANCE-Con01~VANCE-Con03 constructed in Example 1 were inoculated into 50 mL of seed culture medium (TB medium) and cultured at 37°C and 200 rpm until OD 600 About 0.7, 0.1 mM IPTG was added, and the culture was induced at 20℃ for 24 h. The overnight culture was centrifuged and the supernatant was removed. 0.1 g of the bacteria were ultrasonically broken and added with 5 mL of the reaction solution containing 50 g / L ferulic acid for 18 hours. The concentration of vanillin was determined by HPLC. The results are shown in Table 8 below.
[0128] Table 8: Biotransformation reaction data
[0129]
[0130] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. Dioxygenase, It is characterized in that The amino acid sequence is shown in SEQ ID NO: 1 or SEQ ID NO:
3.
2. Use of the dioxygenase as claimed in claim 1 in the preparation of vanillin.
3. Nucleic acid molecules, It is characterized in that A nucleotide sequence encoding the dioxygenase according to claim 1.
4. The nucleic acid molecule according to claim 3, It is characterized in that The nucleotide sequence is shown in SEQ ID NO: 2 or SEQ ID NO:
4.
5. Expression vector, It is characterized in that Include: (A1), a nucleotide sequence encoding the dioxygenase according to claim 1; or (A2) A nucleic acid molecule according to claim 3 or 4.
6. The expression vector according to claim 5, It is characterized in that The backbone is pSC101, pRSFDuet or pET21a.
7. Host cells, excluding totipotent cells, It is characterized in that Contains any of the following: (B1), the dioxygenase according to claim 1; (B2), a nucleic acid molecule according to claim 3 or 4; (B3) The expression vector according to claim 5 or 6.
8. Preparation method of dioxygenase, It is characterized in that Prepared based on any of the following: (C1), a nucleic acid molecule according to claim 3 or 4; (C2), the expression vector according to claim 5 or 6; (C3) The host cell according to claim 7.
9. A method for preparing vanillin. It is characterized in that Prepared based on any of the following: (D1), the dioxygenase according to claim 1; (D2), a nucleic acid molecule according to claim 3 or 4; (D3), the expression vector according to claim 5 or 6; (D4) The host cell according to claim 7.
10. The preparation method according to claim 9, It is characterized in that The method comprises the step of reacting the dioxygenase according to claim 1 with a substrate; The substrate concentration of the reaction is 1-50 g / L; The reaction temperature is 20-40°C.
